CSL

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.
CSL
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1916-01-01
Address:
Parkville, New South Wales, Australia
Country:
Australia
Website Url:
http://www.csl.com
Total Employee:
10001+
Status:
Active
Contact:
61393878454
Total Funding:
111 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Amazon JsDelivr Cloudflare JS CDN JS ASP.NET Apple Mobile Web App Capable JQuery CDN
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Ghazal Hariri Investigator @ CSL
Investigator
2019-01-01
John Shine Chairman @ CSL
Chairman
Sandro Krug Human Resources Director Intercontinental Commercial Operations @ CSL
Human Resources Director Intercontinental Commercial Operations
2022-01-01
Joy Linton Chief Financial Officer @ CSL
Chief Financial Officer
2021-03-01
Paul Perreault Chief Executive Office and Managing Director @ CSL
Chief Executive Office and Managing Director
Peter Turner President of CSL Behring @ CSL
President of CSL Behring
Brian A. McNamee CEO @ CSL
CEO
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-12-14 | Vifor Pharma | Vifor Pharma acquired by CSL | 11.7 B USD |
2017-08-28 | Calimmune | Calimmune acquired by CSL | 91 M USD |
2017-06-12 | Wuhan Zhong Yuan Rui De Biological Products | Wuhan Zhong Yuan Rui De Biological Products acquired by CSL | 352 M USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-09-28 | Ena Respiratory | CSL investment in Series A - Ena Respiratory | 11.7 M AUD |
2019-09-26 | Denteric | CSL investment in Series A - Denteric | 14 M AUD |
2000-05-30 | eBioinformatics | CSL investment in Venture Round - eBioinformatics | 10 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-02-24 | DMO appoints CSL as new stockbrokers to FGN |
Official Site Inspections
http://www.csl.com Semrush global rank: 318.65 K Semrush visits lastest month: 194.8 K
- Host name: csl.com
- IP address: 12.3.33.229
- Location: Atlanta United States
- Latitude: 33.9707
- Longitude: -84.3247
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30338
